Research in Social and Administrative Pharmacy
Volume 6, Issue 4 , Pages 345-353 , December 2010

Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa

  • Karine Wabø Ruud, M.Pharm.

      Affiliations

    • Department of Social Pharmacy, School of Pharmacy, University of Oslo, Pb 1068 Blindern, Oslo 0316, Norway
    • Corresponding Author InformationCorresponding author. Tel.: +47 22 85 65 85; fax: +47 22 85 44 02.
    • ,
  • Sunitha C. Srinivas, M.Pharm., P.G.D.H.E, Ph.D.

      Affiliations

    • Pharmacy Administration and Practice, Faculty of Pharmacy, Rhodes University, Grahamstown 6140, South Africa
    • ,
  • Else-Lydia Toverud, M.Pharm., Ph.D.

      Affiliations

    • Department of Social Pharmacy, School of Pharmacy, University of Oslo, Pb 1068 Blindern, Oslo 0316, Norway

References 

  1. UNAIDS, WHO . AIDS Epidemic Update December 2007. Geneva, Switzerland: UNAIDS, WHO; 2007;
  2. Benatar SR. Health care reform and the crisis of HIV and AIDS in South Africa. N Engl J Med. 2004;351(1):81–92
  3. Hall EJ. Nursing attrition and the work environment in South African health facilities. Curationis. 2004;27(4):28–36
  4. Grubb I, Perriëns J, Schwartländer B. A Public Health Approach to Antiretroviral Treatment: Overcoming Constraints. Geneva, Switzerland: World Health Organization; 2003;
  5. Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2007;65(3):396–406
  6. Katende-Kyenda NL, Lubbe MS, Serfontein JH, Truter I. Prevalence of drug-drug interactions of antiretroviral agents in the private health care sector in South Africa. S Afr Med J. 2008;98(2):109–113
  7. WHO. Pharmacovigilance for antiretrovirals in resource-poor countries. Geneva, Switzerland: WHO 2007.
  8. Hughes ML, Whittlesea CM, Luscombe DK. Review of national spontaneous reporting schemes. Strengths and weaknesses. Adverse Drug React Toxicol Rev. 2002;21(4):231–241
  9. Fomundam H, Meyers G, Kayongo D. Models of care project (HIV/AIDS treatment programme). Pharmacovigilance plan and training, Grahamstown Settlers hospital: Eastern Cape Regional Training Centre (ECRTC); 2007.
  10. Bäckström M, Mjörndal T, Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf. 2002;11(8):647–650
  11. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19–31
  12. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623–627
  13. Hasford J, Goettler M, Munter KH, Müller-Oerlinghausen B. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol. 2002;55(9):945–950
  14. Okezie EO, Olufunmilayo F. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf. 2008;17(5):517–522
  15. Khoza S, Madungwe I, Nyambayo P, Mthethwa J, Chikuni O. Adverse drug reactions reporting at a referral hospital in Zimbabwe. Cent Afr J Med. 2004;50(11-12):104–107
  16. Ekbom Y, Hedenmalm K, Dalin L, Lönnroth K, Persson I. Reporting of side-effects—a system in need of improvement. Reporting of a physician questionnaire. Lakartidningen. 2002;99(34):3290–3295
  17. Roberts KJ. Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care STDS. 2000;14(3):155–168
  18. Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34(3):281–288
  19. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS. 2003;17(4):169–177
  20. Li Q, Zhang SM, Chen HT, et al. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl). 2004;117(6):856–861
  21. HST . South African Health Review 2008. Durban, South Africa: Health Systems Trust; 2008;
  22. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009;9(14):
  23. Pedrós C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009;32(1):77–83
  24. Adverse Drug Reaction and Medicine Review Committee . Evaluation of a training course on pharmacovigilance in sub-Saharan Africa. Pharmacoepidemiol Drug Saf. 2000;9(2):133–138
  25. Sevene E, Mariano A, Metha U, et al. Spontaneous adverse drug reaction reporting in rural districts of Mozambique. Drug Saf. 2008;31(10):867–876

PII: S1551-7411(09)00144-2

doi: 10.1016/j.sapharm.2009.11.006

Research in Social and Administrative Pharmacy
Volume 6, Issue 4 , Pages 345-353 , December 2010

Article Tools